{
    "2019-06-12": [
        [
            {
                "time": "2019-06-12",
                "original_text": "Galapagos Ends Enrollment in Osteoarthritis Study Before Time",
                "features": {
                    "keywords": [
                        "Galapagos",
                        "Enrollment",
                        "Osteoarthritis",
                        "Study"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-12",
                "original_text": "Novartis Reports Data on Cosentyx for Psoriatic Arthritis",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Cosentyx",
                        "Psoriatic",
                        "Arthritis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-12",
                "original_text": "Pfizer (PFE) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Gains",
                        "Market",
                        "Dips"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-12",
                "original_text": "Top Ranked Income Stocks to Buy for June 12th",
                "features": {
                    "keywords": [
                        "Income",
                        "Stocks",
                        "Buy",
                        "June"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-12",
                "original_text": "Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer",
                "features": {
                    "keywords": [
                        "Merck",
                        "Keytruda",
                        "FDA",
                        "Nod",
                        "Head/Neck",
                        "Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-06-12",
                "original_text": "Boost Your Portfolio's Health With These 3 Big Drug Stocks",
                "features": {
                    "keywords": [
                        "Portfolio",
                        "Health",
                        "Drug",
                        "Stocks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-12",
                "original_text": "Health Care Sector Update for 06/12/2019: SYBX, CTRV, AXGT, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Sector",
                        "Update",
                        "SYBX",
                        "CTRV",
                        "AXGT",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-12",
                "original_text": "Pfizer Announces Results from XELJANZÂ® XR (tofacitinib) ORAL Shift Study, The First Phase 3b/4 Study to Evaluate Methotrexate Withdrawal with a JAK Inhibitor",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "XELJANZ",
                        "XR",
                        "tofacitinib",
                        "ORAL",
                        "Shift",
                        "Study",
                        "Phase",
                        "3b/4",
                        "Methotrexate",
                        "Withdrawal",
                        "JAK",
                        "Inhibitor"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}